Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Income from Discontinued Operations (2019 - 2022)

Analysis

Precigen (PGEN) Income from Discontinued Operations (2019 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 95.02 Mn
Jun 30, 2022 8.42 Mn
Mar 31, 2022 4.65 Mn
Dec 31, 2021 1.66 Mn
Sep 30, 2021 -3.45 Mn
Jun 30, 2021 10.89 Mn
Mar 31, 2021 4.53 Mn
Dec 31, 2020 -1.31 Mn
Sep 30, 2020 -1.97 Mn
Jun 30, 2020 -27.65 Mn
Mar 31, 2020 -35.15 Mn
Dec 31, 2019 -133.14 Mn
Sep 30, 2019 -4.58 Mn
Jun 30, 2019 -6.63 Mn
Mar 31, 2019 -9.24 Mn